Effect of exogenous glucocorticoid on osmotically stimulated antidiuretic hormone secretion and on water reabsorption in man

European Journal of Endocrinology

Volumn 155, Issue 6, 2006, Pages 845-848

  Bähr, Volker ^a   Franzen, Norma ^a   Oelkers, Wolfgang ^b   Pfeiffer, Andreas F H ^a   Diederich, Sven ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Endokrinologikum Berlin   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; GLUCOCORTICOID; PREDNISOLONE; VASOPRESSIN; WATER;

ADULT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OSMOLALITY; OSMOSIS; PRIORITY JOURNAL; STIMULATION; URINE LEVEL; VASOPRESSIN BLOOD LEVEL; VASOPRESSIN RELEASE; VOLUNTEER; WATER ABSORPTION; WATER DEPRIVATION;

ADULT; BODY WATER; CYCLIC AMP; GLUCOCORTICOIDS; HUMANS; KIDNEY CONCENTRATING ABILITY; MALE; OSMOLAR CONCENTRATION; PREDNISOLONE; VASOPRESSINS; WATER DEPRIVATION;

EID: 33845992180     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02299     Document Type: Article

References (27)

1. Milsom SR, Conaglen JV, Donald RA, Espiner EA, Nicholls MG & Livesey JH. Augmentation of the response to CRF in man: relative contributions of endogenous angiotensin and vasopressin. Clinical Endocrinology 1985 22 623-629.
2. Bähr V, Hensen J, Hader O & Oelkers W. Effects of osmotically stimulated endogenous vasopressin on basal and CRH-stimulated ACTH release in man. Acta Endocrinologica 1988 117 103-108.
3. Graf MV, Kastin AJ & Fischman AJ. Interaction of arginine vasopressin and corticotropin releasing factor demonstrated with an improved bioassay. Proceedings of the Society for Experimental Biology and Medicine 1985 179 303-308.
4. Oelkers W. Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism (see comments). New England Journal of Medicine 1989 321 492-496.
5. Diederich S, Franzen NF, Bähr V & Oelkers W. Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases. European Journal of Endocrinology 2003 148 609-617.
6. Papanek PE & Raff H. Chronic physiological increases in cortisol inhibit the vasopressin response to hypertonicity in conscious dogs. American Journal of Physiology 1994 267 R1342-R1349.
7. Raff H, Skelton MM & Cowley AW Jr. Feedback control of vasopressin and corticotrophin secretion in conscious dogs: effect of hypertonic saline. Journal of Endocrinology 1989 122 41-48.
8. Biewenga WJ, Rijnberk A & Mol JA. Osmoregulation of systemic vasopressin release during long-term glucocorticoid excess: a study in dogs with hyperadrenocorticism. Acta Endocrinologica 1991 124 583-588.
9. Diederich S, Eckmanns T, Exner P, Al Saadi N, Bähr V & Oelkers W. Differential diagnosis of polyuric/polydipsic syndromes with the aid of urinary vasopressin measurement in adults. Clinical Endocrinology 2001 54 665-671.
10. Morton JJ, Connell JM, Hughes MJ, Inglis GC & Wallace EC. The role of plasma osmolality, angioterisin II and dopamine in vasopressin release in man. Clinical Endocrinology 1985 23 129-138.
11. Robertson GL & Ganguly A. Osmoregulation and baroregulation of plasma vasopressin in essential hypertension. Journal of Cardiovascular Pharmacology 1986 8 (Suppl 7) S87-S91.
12. Boscaro M, Barzon L, Fallo F & Sonino N. Cushing's syndrome. Lancet 2001 357 783-791.
13. Allotio B. In Praktische Endokrinologie, pp 219-227. Ed. B Allolio, München, Wien, Baltimore: Urban und Schwarzenberg, 2006.
14. Li C, Wang W, Summer SN, Cadnapaphornchai MA, Falk S, Umenishi F & Schrier RW. Hyperosmolality in vivo upregulates aquaporin 2 Water channel and Na-K-2Cl co-transporter in brattleboro, rats. Journal of the American Society of Nephrology 2006 17 1657-1664.
15. Marples D, Christensen BM, Frokiaer J, Knepper MA & Nielsen S. Dehydration reverses vasopressin antagonist-induced diuresis and aquaporin-2 downregulation in rats. American Journal of Physiology 1998 275 F400-F409.
16. Pedersen RS, Bentzen H, Bech JN & Pedersen EB. Effect of an acute oral ibuprofen intake on urinary aquaporin-2 excretion in healthy humans. Scandinavian Journal of Clinical and Laboratory Investigation 2001 61 631-640.
17. Matsumura Y, Uchida S, Rai T, Sasaki S & Marumo, F. Transcriptional regulation of aquaporin-2 water channel gene by cAMP. Journal of the American Society of Nephrology 1997 8 861-867.
18. Yasui M, Zelenin SM, Celsi G & Aperia A. Adenylate cyclase-coupled vasopressin receptor activates AQP2 promoter via a dual effect on CRE and AP1 elements. American Journal of Physiology. Renal Physiology 1997 272 F443-F450.
19. Lee YJ, Song IK, Jang KJ, Nielsen J, Frokiaer J, Nielsen S & Kwon TH. Increased AQP2 targeting in primary cultured IMCD cells in response to angiotensin II through AT1 receptor. Renal Physiology 2006 [epub ahead of print].
20. Teitelbaum I, Strasheim A & Berl T. Adrenergic control of cAMP generation in rat inner medullary collecting tubule cells. Kidney International 1989 35 647-653.
21. Veis JH, Dillingham MA & Berl T. Effects of prostacyclin on the cAMP system in cultured rat inner medullary collecting duct cells. American Journal of Physiology. Renal Physiology 1990 258 F1218-F1223.
22. Hasler U, Jeon US, Kim JA, Mordasini D, Kwon HM, Feraille E & Martin PY. Tonicity-responsive enhancer binding protein is an essential regulator of aquaporin-2 expression in renal collecting duct principal cells. Journal of the American Society of Nephrology 2006 17 1521-1531.
23. Storm R, Klussmann E, Geelhaar A, Rosenthal W & Marie K. Osmolality and solute composition are strong regulators of AQP2 expression in renal principal cells. American Journal of Physiology. Renal Physiology 2003 284 F189-F198.
24. Sato M & Dunn MJ. Interactions of vasopressin, prostaglandins, and cAMP in rat renal papillary collecting tubule cells in culture. American Journal of Physiology. Renal Physiology 1984 247 F423-F433.
25. Zelenina M, Christensen BM, Palmer J, Nairn AC, Nielsen S & Aperia A. Prostaglandin E(2) interaction with AVP: effects on AQP2 phosphorylation and distribution. American Journal of Physiology, Renal Physiology 2000 278 F388-F394.
26. Turesin F, del SP & Wallace JL. Enhanced anti-inflammatory potency of a nitric oxide-releasing prednisolone derivative in the rat. British Journal of Pharmacology 2003 139 966-972.
27. Goppelt-Struebe M. Molecular mechanisms involved in the regulation of prostaglandin biosynthesis by glucocorticoids. Biochemical Pharmacology 1997 53 1389-1395.